William B. Daviss, M.D., etal. (2016) Use of Antipsychotic Medications for Nonpsychotic Children: Risks and Implications for Mental Health Services
McFarlane, W., Levin, B., Travis, L., Lucas, F., Lynch, S., Verdi, M., et al. (2014). Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial.
J. Michael Murphy, EdD, Alyssa E. McCarthy, BA, Lee Baer, PhD, Bonnie T. Zima, MD, MPH, and Michael S. Jellinek, MD (2014). Alternative National Guidelines for Treating Attention and Depression Problems in Children: Comparison of Treatment Approaches and Prescribing Rates in the United Kingdom and United States
Zima, B.T., Bussing, R., Tang, L., Zhang, L., Ettner, S., Belin, T.R., et al. (December 2010). Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care Medicaid program.
Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression.
Smith, Grant, Jongeling, B., Hartmann, P., Russell, C. & Landau, L. Raine (ND). ADHD Study: Long-term outcomes associated with stimulant medication in the treatment of ADHD in children.
Molina, B.S.G., Hinshaw, S.P., Swanson, J.M., Arnold, L.E., Vitiello, B., Jensen, P.S., et al. (2009). MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study.
Jureidini, J.N., Doecke, C.J., Mansfield, P.R., Haby, M.M., Menkes, D.B. & Tonkin, A.L. (2004). Efficacy and safety of antidepressants for children and adolescents.
Jensen, P., Arnold, L.E., Swanson, J.M., Vitiello, B., Abikoff, H.B., Greenhill, L.L. (2007). 3-year follow-up of the NIMH MTA study.
Geller, B., Zimmerman, B., Williams, M., Bolhofner, K. & Craney, J. (January 2001). Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder.
